PPP1R15A
- 1 lab in 1 country
- 1 trial
- Funder: Japan Society for the Promotion of Science
- 1 of 1 trial sponsored by developers of drugs on it
- Animals1
Effects
3Insulin resistance
downin mice1
1 study
Insulin resistance
downin mice1
PPP1R15A prevents insulin resistance in mice.
“with age GADD34-deficient mice become obese, developing fatty liver followed by liver cirrhosis, hepatocellular carcinoma, and insulin resistance.”
Animalswith age
Scientific reports28 Aug 2015
Hepatocellular carcinoma
downin mice1
1 study
Hepatocellular carcinoma
downin mice1
PPP1R15A prevents hepatocellular carcinoma in mice.
“with age GADD34-deficient mice become obese, developing fatty liver followed by liver cirrhosis, hepatocellular carcinoma, and insulin resistance.”
Animalswith age
Scientific reports28 Aug 2015
Obesity
downin mice1
1 study
Obesity
downin mice1
PPP1R15A prevents obesity in mice.
“with age GADD34-deficient mice become obese, developing fatty liver followed by liver cirrhosis, hepatocellular carcinoma, and insulin resistance.”
Animalswith age / in aged mice
Scientific reports28 Aug 2015
Latest
Scientific Reports
GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance
Experiments in miceMechanisms